The lower, the better? : fractional polynomials meta-regression of blood pressure reduction on stroke risk

Hisato Takagi1, Takuya Umemoto

  • 1Department of Cardiovascular Surgery, Shizuoka Medical Center, 762-1 Nagasawa, Shimizu-cho, Sunto-gun, Shizuoka, 411-8611, Japan, kfgth973@ybb.ne.jp.

Insights

Lowering systolic blood pressure (SBP) significantly reduces stroke risk. However, excessive SBP reduction beyond 13.7 mmHg with single-drug therapy offers no additional stroke risk reduction in primary prevention.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Pharmacology
  • Epidemiology

Background:

  • Blood pressure (BP) lowering drugs significantly reduce stroke risk.
  • A 10 mmHg reduction in systolic BP (SBP) or 5 mmHg in diastolic BP is associated with a one-third reduction in stroke incidence.

Purpose of the Study:

  • To determine the optimal extent of BP lowering for stroke risk reduction.
  • To investigate potential limits to BP reduction benefits in primary prevention.

Main Methods:

  • Meta-regression analysis of 17 primary-prevention trials.
  • Utilized fractional polynomials for flexible, non-linear modeling of SBP reduction and stroke risk.
  • Calculated relative risks (RRs) for stroke incidence based on SBP reduction.

Main Results:

  • An inverse J-shaped dose-response relationship was observed between SBP reduction and stroke risk.
  • The nadir, or optimal point for stroke risk reduction, occurred at a 13.7 mmHg SBP reduction.
  • The best-fitting model showed a significant gain in deviance compared to a linear model.

Conclusions:

  • Single-drug therapy for BP lowering may have a threshold for stroke risk reduction.
  • Reductions in SBP exceeding 13.7 mmHg in primary prevention settings do not appear to offer further stroke risk benefits.
  • These findings suggest a potential limit to the benefits of intensive BP lowering with monotherapy.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.